4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001567619-21-005398
Options or other derivatives
- Chief Medical Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HANNAH ALISON L. · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-26 | Grant or award : show line 1 in the form Stock Option (right to buy) | +175,000 | 175,000 | D |
Loading xslF345X03/doc1.xml…